Maury Raycroft

Stock Analyst at Jefferies

(0)
# 4598
Out of 5,372 analysts
78
Total ratings
25.00%
Success rate
-13.13%
Average return
Main Sectors:
Top Industries:
41 Stocks
Name Action PT Current % Upside Ratings Updated
CRBP Corbus Pharmaceutica...
Maintains: Buy
70 53
8.31 537.79% 2 Mar 11, 2025
CMRX Chimerix
Downgrades: Hold
10 9
n/a n/a 2 Mar 5, 2025
CMPX Compass Therapeutics
Maintains: Strong Buy
7 8
2.19 265.3% 2 Feb 10, 2025
SGMO Sangamo Therapeutics
Maintains: Buy
7 3
n/a n/a 1 Dec 31, 2024
MREO Mereo BioPharma Grou...
Initiates Coverage On: Buy
7
2.8 150% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.37 337.96% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Strong Buy
16 17
3.98 327.14% 1 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
4.8 295.83% 1 Jul 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
58 39
n/a n/a 2 May 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
23 15
1.61 831.68% 1 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 39
17.25 126.09% 2 Mar 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
0.57 952.63% 1 Mar 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
1.46 1475.34% 1 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
195
6.75 2788.89% 1 Feb 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
55 58
n/a n/a 7 Oct 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
11
9.98 10.22% 8 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
104 173
n/a n/a 3 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
4 2
n/a n/a 1 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
6 9
n/a n/a 2 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
32 6
21.16 -71.64% 2 Jan 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
92 75
15.51 383.56% 4 Nov 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
35 36
n/a n/a 2 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
218 232
308.84 -24.88% 1 Oct 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
4.14 165.7% 1 Sep 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 20
n/a n/a 1 Sep 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
39 55
n/a n/a 1 Apr 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
31 27
9.6 181.25% 3 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
38 5
3.42 46.2% 2 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
12 17
n/a n/a 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
n/a n/a 1 Nov 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
48
11.82 306.09% 1 Sep 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
320
n/a n/a 1 Jul 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
36
5.9 510.17% 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
105
4.61 2177.66% 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
172
43.19 298.24% 2 Apr 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
n/a n/a 1 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
47
2.31 1934.63% 1 Feb 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 2
n/a n/a 2 Jan 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
18 40
n/a n/a 5 Aug 28, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
230
4.11 5496.11% 1 Jul 16, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 42
9.58 338.41% 3 Nov 1, 2017